DNER and type 2 diabetes mellitus: We implicated Brd2 in obesity and Type 2 diabetes seven years ago, when we published the first paper showing that reduced expression of this BET isoform promotes pancreatic β-cell proliferation and function [30], as well as attenuated inflammation [32] and improved adipogenesis in mouse and tissue culture models [30].